Second Sight Medical (EYES) IPO Immediately Halted on Opening Surge

Go back to Second Sight Medical (EYES) IPO Immediately Halted on Opening Surge

Second Sight Medical (EYES) Sees Profit Taking after 162% Post-IPO Surge

November 21, 2014 10:25 AM EST

This week's hot IPO for Second Sight Medical (NASDAQ: EYES) is giving some back today. After gaining 162% in it fist two days of trading, shares are down 9.5% to $21.35 today. The IPO priced at $9.

Second Sight develops, manufactures and markets implantable visual prosthetics to restore some functional vision to blind patients

... More

Second Sight Medical (EYES) Momentum Continues Following Robust IPO

November 20, 2014 8:44 AM EST

Second Sight Medical (NASDAQ: EYES) is showing early gains Thursday following the company's strong debut on yesterday's session.

Wednesday, Second Sight opened for trading at $17 after pricing 3.5 million common shares at $9 apiece. Overall, the stock close 122 percent higher to $19.97.

Ahead of the bell, Second Sight is up an additional 15 percent.

... More

Second Sight Medical (EYES) Picks Up Chatter Ahead of CNBC Coverage

November 19, 2014 12:50 PM EST

While off the highs, traders are getting chatty about today's IPO for Second Sight Medical Products (NASDAQ: EYES) as it is expected to be highlighted on CNBC in a little while. Shares are up 105% at last check to $18.50 after pricing at $9.

... More